New heart mapping method could cut repeat ablations
NCT ID NCT05239364
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two approaches for treating atrial tachycardia that occurs after atrial fibrillation ablation or heart surgery. One group gets standard ablation targeting all abnormal heart circuits, while the other gets a more focused ablation guided by a new ultra-high-density mapping system. The goal is to see if the targeted approach reduces the chance of arrhythmia coming back. About 100 adults who have had prior AF ablation or heart surgery and now have a stable atrial tachycardia will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- catheter ablation (radiofrequency)
- What this could lead to
- If successful, this approach could reduce the number of repeat procedures needed for atrial tachycardia after atrial fibrillation treatment or heart surgery.
- What could go wrong
- This is an early-stage study with 100 participants, so results may not apply to all patients. The procedure carries standard risks of catheter ablation, such as bleeding or heart tissue damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARRHYTHMIAS, CARDIAC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asklepios St. Georg
RECRUITINGHamburg, Free and Hanseatic City of Hamburg, Germany
-
Evangelic Hospital Düsseldorf
RECRUITINGDüsseldorf, North Rhine-Westfalia, 40217, Germany
-
Evangelic Hospital Hagen-Haspe
RECRUITINGHagen, Germany
-
Städtisches Klinikum Karlsruhe
RECRUITINGKarlsruhe, Germany
-
Universitätsklinikum Schleswig Holstein
RECRUITINGKiel, Germany
-
Vivantes Klinikum Am Urban Berlin
RECRUITINGBerlin, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fixing sleep, fortifying hearts: a new trial tests the link
- Can a single gene infusion rebuild failing hearts?
- Can a 3D virtual world rehab your heart?
- Can your genes predict blood thinner effectiveness?
- Can a dual energy catheter tame dangerous heart rhythms?
- Can a Stick-On AI patch replace wires for heart monitoring after surgery?